News

  • Best Ways Save April 2017

    Despite these obstacles, Rep. Rogers and Sen. Mikulski have said they remain committed to passing an omnibus this year, and they have reportedly instructed their aides to have a line-by-line spending plan ready by December 8th. TSCL is hopeful that a compromise can be reached before the looming deadline, since failing to do so would likely have a negative effect on Social Security and Medicare beneficiaries. In the coming weeks, we will continue to keep a close eye on the evolving discussions, and we will post updates here in the Legislative News section of our website. .The changes closed two claiming tactics known as "file and suspend" and "restricted application for spousal benefits." The claiming strategies have made it possible for both members of a couple who are 66 or older to delay claiming Social Security based on their own earnings records, in order to increase payments, while at the same time one spouse receives a spousal benefit. Alicia Munnell of The Center for Retirement Research at Boston College estimates the changes would save .5 billion per year — a potential cost that would grow over time. .The new low comes as COLAs have flat-lined over the past seven years, averaging just 1.2% — less than half the 3% average over the two decades prior to 20The long-term financial impact on anticipated retirement benefits is significant and growing, says TSCL's Executive Director, Shannon Benton. "People lose the effect of compounding when benefit raises are at these extreme lows," she explains. "That reduces the Social Security income that retirees may have been counting on over their retirement." … Continued

  • Q A

    In his opening statement, Congressman Buddy Carter (GA-1) – the sole pharmacist in Congress – said, "I'm disgusted that we're here today to talk about drug price increases … I know free market principles are the best way to provide quality, affordable health care to the American people. But what was done here was different. Perverse business practices were employed to exploit a patient group trying to do nothing more than to extend their lives … I'll tell you that you can meet your shareholders' needs, that you can meet your board's needs, and still take care of the American public." .TSCL encourages its members and supporters to attend these events and to voice their concerns about important Social Security and Medicare issues like inadequate cost-of-living adjustments and skyrocketing prescription drug prices. .What cost increases should you keep an eye on in 2015? Prescription drugs! To learn more see "Unprecedented Generic Drug Price Spikes Wreaking Havoc." … Continued

As our nation goes through the process of getting vaccinated for COVID-19 and getting our lives back on track, TSCL is working on a number of long-term issues that await Congressional attention. We expect policy makers in Congress will be turning their attention to the question of boosting benefits and restoring the long-term solvency of the Medicare and Social Security Trust Funds. .CBO is strictly nonpartisan; conducts objective, impartial analysis; and hires its employees solely on the basis of professional competence without regard to political affiliation. CBO does not make policy recommendations, and each report and cost estimate summarizes the methodology underlying the analysis. .The total cost for a single year of treatment with the nation's most expensive specialty drugs can cost more than the entire retirement savings for many retirees. The annual cost of the cancer drug Idhifa, for example, is 0,85According to a new study by the non-partisan Kaiser Family Foundation, the median out-of-pocket cost that Medicare Part D beneficiaries will pay out-of-pocket for specialty drugs in 2019 would be ,55Patients suffering from multiple sclerosis could pay an estimated out-of-pocket of ,409 in 2019 for Glatiramer acetate. Even on the "low side," the annual out-of-pocket for Hepatitis C drug, Zepatier runs ,622. .What you can do: To sign a petition, click here. .Fortunately, H.R. 3 is not the only legislation in either house of Congress that could lower drug prices and accomplish the other things necessary to fix Medicare and Social Security. .To be fair, the House of Representatives, for the most part, got its work done on time. It was once again the Senate that failed to do what it is supposed to do and pass the funding legislation that is needed for the new fiscal year which will begin on October 1. .It is indisputable that Americans are, on average, living longer lives. According to data from the Centers for Disease Control, someone who turned 65 in 1950 had, on average, 13.9 more years to live, while someone who turned 65 in 2007 had, on average, 18.6 more years to live. The 2009 Social Security Trustees Report also projected that over the next 25 years the life expectancy at age 65 will increase to 19.5 more years. Many cite this as a reason to support increasing the retirement age. Also, by encouraging workers to stay in the work force longer, more revenue will come into Social Security's coffers. .Lawmakers will likely pass a short-term bill that will provide funding through Friday, May 5th. The seven-day stopgap measure will buy time for lawmakers to continue working on a larger omnibus spending bill that will fund the government through September 30th – the end of the fiscal year. .Each year, due to a faulty formula that's used to determine Medicare's reimbursement rates, doctors are threatened with sizable pay cuts. This year, if Congress fails to act, doctors will face a 25 percent cut. Lawmakers consistently override scheduled pay cuts with temporary "fixes," but many doctors have grown tired of the ritual and have stopped treating Medicare patients. The estimated cost of repealing the formula has recently dropped dramatically, and many are hoping to replace it in the coming months. Doing so would provide much-needed stability for Medicare beneficiaries.